Cardiol Therapeutics (CRDL) News Today $1.52 +0.13 (+9.06%) Closing price 03:51 PM EasternExtended Trading$1.46 -0.06 (-3.96%) As of 04:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRDL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Analysts Set Cardiol Therapeutics Inc. (NASDAQ:CRDL) Target Price at $8.67June 26, 2025 | americanbankingnews.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Given Average Rating of "Buy" by BrokeragesJune 21, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for CRDL Q2 Earnings?June 4, 2025 | marketbeat.comCardiol Therapeutics Analyst RatingsJune 4, 2025 | benzinga.comCardiol Therapeutics Analyst RatingsJune 4, 2025 | benzinga.comHC Wainwright & Co. Initiates Coverage of Cardiol Therapeutics (CRDL) with Buy RecommendationJune 2, 2025 | msn.comCardiol Therapeutics (NASDAQ:CRDL) Coverage Initiated at HC WainwrightJune 2, 2025 | marketbeat.comCardiol Therapeutics Reports Q1 2025 Financial ResultsMay 27, 2025 | tipranks.com487,295 Shares in Cardiol Therapeutics Inc. (NASDAQ:CRDL) Bought by PVG Asset Management CorpMay 27, 2025 | marketbeat.comCardiol Therapeutics Reports Q1 2025 Financial ResultsMay 14, 2025 | tipranks.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Given Consensus Rating of "Buy" by AnalystsMay 10, 2025 | marketbeat.comEnvestnet Asset Management Inc. Makes New Investment in Cardiol Therapeutics Inc. (NASDAQ:CRDL)May 8, 2025 | marketbeat.comAdvisorShares Investments LLC Lowers Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL)May 1, 2025 | marketbeat.comCardiol Therapeutics (CRDL) Projected to Post Earnings on MondayApril 20, 2025 | marketbeat.comResearch Analysts Offer Predictions for CRDL Q1 EarningsApril 20, 2025 | marketbeat.comCardiol Therapeutics starts phase III trial for heart drugApril 18, 2025 | uk.investing.comRoth MKM Sticks to Its Buy Rating for Cardiol Therapeutics (CRDL)April 18, 2025 | markets.businessinsider.comCardiol Therapeutics (NASDAQ:CRDL) Earns Buy Rating from HC WainwrightApril 18, 2025 | marketbeat.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Consensus Rating of "Buy" from BrokeragesApril 15, 2025 | marketbeat.comCardiol Therapeutics Reports Increased Losses Amid Rising ExpensesApril 14, 2025 | tipranks.comWhat is HC Wainwright's Forecast for CRDL FY2025 Earnings?April 12, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Cardiol Therapeutics (NASDAQ:CRDL)April 9, 2025 | marketbeat.comWe're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn RateApril 2, 2025 | finance.yahoo.comCardiol Therapeutics (NASDAQ:CRDL) Releases Earnings Results, Beats Expectations By $0.01 EPSApril 1, 2025 | marketbeat.comCardiol Therapeutics (CRDL) Projected to Post Quarterly Earnings on MondayMarch 31, 2025 | marketbeat.comTejara Capital Ltd Buys 1,344,167 Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL)March 19, 2025 | marketbeat.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Recommendation of "Buy" from BrokeragesMarch 19, 2025 | marketbeat.comShort Interest in Cardiol Therapeutics Inc. (NASDAQ:CRDL) Increases By 26.4%March 18, 2025 | marketbeat.comCardiol Therapeutics' (CRDL) Buy Rating Reiterated at HC WainwrightFebruary 24, 2025 | marketbeat.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Rating of "Buy" from AnalystsFebruary 22, 2025 | marketbeat.comCardiol Therapeutics says study shows benefit of cannabidiol drug in treating heart failureFebruary 20, 2025 | proactiveinvestors.comCardiol Therapeutics: Bargain Stock Price With Share Price Appreciation CatalystsFebruary 19, 2025 | seekingalpha.comShort Interest in Cardiol Therapeutics Inc. (NASDAQ:CRDL) Drops By 8.3%February 18, 2025 | marketbeat.comRODMAN&RENSHAW Upgrades Cardiol Therapeutics (NASDAQ:CRDL) to Strong-BuyJanuary 29, 2025 | marketbeat.comCardiol Therapeutics initiated with a Buy at Rodman & RenshawJanuary 28, 2025 | markets.businessinsider.comRodman & Renshaw sets $7 target on Cardiol Therapeutics stockJanuary 28, 2025 | msn.comCardiol Therapeutics (NASDAQ:CRDL) Earns Buy Rating from Analysts at Rodman & RenshawJanuary 28, 2025 | marketbeat.comCardiol Therapeutics Inc. (NASDAQ:CRDL) Short Interest Up 12.4% in DecemberJanuary 1, 2025 | marketbeat.comHC Wainwright Has Positive Outlook for CRDL FY2024 EarningsDecember 20, 2024 | marketbeat.comPRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent PericarditisDecember 19, 2024 | globenewswire.comCardiol Therapeutics (NASDAQ:CRDL) Earns "Buy" Rating from HC WainwrightDecember 18, 2024 | marketbeat.com3 Penny Stocks Ready to Break Out in 2025Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.November 29, 2024 | marketbeat.comWhat is HC Wainwright's Forecast for CRDL FY2024 Earnings?November 22, 2024 | marketbeat.comEdward Nash Reaffirms Buy Rating for Cardiol Therapeutics: Positive Phase II Data and Strategic Future Trials Boost Market PotentialNovember 21, 2024 | markets.businessinsider.comFY2024 Earnings Forecast for CRDL Issued By Leede FinancialNovember 21, 2024 | marketbeat.comRoth Capital Issues Pessimistic Forecast for CRDL EarningsNovember 21, 2024 | marketbeat.comCardiol Therapeutics' (CRDL) "Buy" Rating Reiterated at HC WainwrightNovember 20, 2024 | marketbeat.comLeede Financial Has Negative View of CRDL FY2027 EarningsNovember 20, 2024 | marketbeat.comCardiol Therapeutics Reports Promising Phase II ResultsNovember 18, 2024 | markets.businessinsider.comCardiol Therapeutics reports promising Phase II results for recurrent pericarditis therapyNovember 18, 2024 | proactiveinvestors.com Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRDL Media Mentions By Week CRDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRDL News Sentiment▼0.000.54▲Average Medical News Sentiment CRDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRDL Articles This Week▼01▲CRDL Articles Average Week Get Cardiol Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ORGO News SIGA News CGEM News ATYR News KMDA News ATAI News TRML News MREO News RGNX News PGEN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRDL) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $100 Trillion AI Story No One Is Telling YouJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiol Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiol Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
